Emina Halilbasic

5.6k total citations
77 papers, 3.5k citations indexed

About

Emina Halilbasic is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, Emina Halilbasic has authored 77 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Epidemiology, 47 papers in Hepatology and 25 papers in Oncology. Recurrent topics in Emina Halilbasic's work include Liver Disease Diagnosis and Treatment (48 papers), Liver Diseases and Immunity (38 papers) and Drug Transport and Resistance Mechanisms (25 papers). Emina Halilbasic is often cited by papers focused on Liver Disease Diagnosis and Treatment (48 papers), Liver Diseases and Immunity (38 papers) and Drug Transport and Resistance Mechanisms (25 papers). Emina Halilbasic collaborates with scholars based in Austria, United States and Germany. Emina Halilbasic's co-authors include Michael Trauner, Peter Fickert, Thierry Claudel, Tarek Moustafa, Claudia Fuchs, Hanns–Ulrich Marschall, Helmut Denk, Gernot Zollner, G. Paumgartner and Martin Wagner and has published in prestigious journals such as Gastroenterology, American Journal of Clinical Nutrition and Hepatology.

In The Last Decade

Emina Halilbasic

74 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emina Halilbasic Austria	32	1.7k	1.6k	1.4k	1.3k	589	77	3.5k
Dagmar Silbert Austria	21	1.1k 0.6×	1.8k 1.1×	919 0.6×	1.2k 0.9×	318 0.5×	42	2.6k
Gernot Zollner Austria	38	2.3k 1.3×	3.8k 2.4×	2.0k 1.4×	2.4k 1.8×	816 1.4×	87	5.9k
Martin Wagner Austria	41	2.6k 1.5×	3.3k 2.0×	1.8k 1.2×	2.2k 1.7×	1.2k 2.0×	81	6.2k
Tadashi Ikegami Japan	28	846 0.5×	743 0.5×	556 0.4×	880 0.7×	962 1.6×	110	2.7k
Antoinette Lemoine France	39	1.4k 0.8×	1.3k 0.8×	2.0k 1.4×	1.7k 1.3×	1.2k 2.0×	134	5.0k
Curt Einarsson Sweden	30	725 0.4×	1.6k 1.0×	300 0.2×	1.8k 1.3×	870 1.5×	64	3.4k
P. L. M. Jansen Netherlands	34	764 0.4×	1.7k 1.0×	639 0.4×	898 0.7×	1.0k 1.8×	79	3.8k
Benjamin L. Woolbright United States	28	857 0.5×	628 0.4×	728 0.5×	608 0.5×	915 1.6×	64	2.8k
Carsten Gartung Germany	27	628 0.4×	1.3k 0.8×	506 0.4×	833 0.6×	418 0.7×	55	2.3k
Meenakshisundaram Ananthanarayanan United States	32	703 0.4×	1.9k 1.2×	387 0.3×	1.5k 1.1×	708 1.2×	55	2.9k

Countries citing papers authored by Emina Halilbasic

Since Specialization

Citations

This map shows the geographic impact of Emina Halilbasic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emina Halilbasic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emina Halilbasic more than expected).

Fields of papers citing papers by Emina Halilbasic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emina Halilbasic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emina Halilbasic. The network helps show where Emina Halilbasic may publish in the future.

Co-authorship network of co-authors of Emina Halilbasic

This figure shows the co-authorship network connecting the top 25 collaborators of Emina Halilbasic. A scholar is included among the top collaborators of Emina Halilbasic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emina Halilbasic. Emina Halilbasic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Semmler, Georg, et al.. (2026). Characterisation and Prognostic Implication of Cholestasis After Burn Injury. Alimentary Pharmacology & Therapeutics. 63(8). 1140–1150.

Hofer, Benedikt, Thomas Reiberger, Albert Friedrich Stättermayer, et al.. (2025). Extending the Baveno VII definition of recompensation to autoimmune hepatitis: Considerations regarding treatment timing and response criteria. JHEP Reports. 8(2). 101667–101667.

Poetter‐Lang, Sarah, Ahmed Ba‐Ssalamah, Alina Messner, et al.. (2024). Disease severity prognostication in primary sclerosing cholangitis: a validation of the Anali scores and comparison with the potential functional stricture. European Radiology. 34(12). 7632–7644. 3 indexed citations

Poetter‐Lang, Sarah, Alina Messner, Nina Bastati, et al.. (2023). Diagnosis of functional strictures in patients with primary sclerosing cholangitis using hepatobiliary contrast-enhanced MRI: a proof-of-concept study. European Radiology. 33(12). 9022–9037. 3 indexed citations

Baumann, Anja, et al.. (2022). A Xanthohumol-Rich Hop Extract Diminishes Endotoxin-Induced Activation of TLR4 Signaling in Human Peripheral Blood Mononuclear Cells: A Study in Healthy Women. International Journal of Molecular Sciences. 23(20). 12702–12702. 10 indexed citations

Halilbasic, Emina, Martin Gajdošík, Marek Chmelík, et al.. (2021). Concentration of Gallbladder Phosphatidylcholine in Cholangiopathies: A Phosphorus‐31 Magnetic Resonance Spectroscopy Pilot Study. Journal of Magnetic Resonance Imaging. 55(2). 530–540. 3 indexed citations

Halilbasic, Emina, Lukasz Japtok, Susanne C. Diesner, et al.. (2020). Plasma Levels of the Bioactive Sphingolipid Metabolite S1P in Adult Cystic Fibrosis Patients: Potential Target for Immunonutrition?. Nutrients. 12(3). 765–765. 10 indexed citations

Traussnigg, Stefan, Emina Halilbasic, Harald Hofer, et al.. (2020). Open-label phase II study evaluating safety and efficacy of the non-steroidal farnesoid X receptor agonist PX-104 in non-alcoholic fatty liver disease. Wiener klinische Wochenschrift. 133(9-10). 441–451. 40 indexed citations

Gajdošík, Martin, Stefan Traussnigg, Christian Kienbacher, et al.. (2019). Metabolic effects of a prolonged, very-high-dose dietary fructose challenge in healthy subjects. American Journal of Clinical Nutrition. 111(2). 369–377. 25 indexed citations

10.

Staufer, Katharina, Emina Halilbasic, Walter Spindelboeck, et al.. (2019). Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease. United European Gastroenterology Journal. 7(8). 1113–1123. 64 indexed citations

11.

Poetter‐Lang, Sarah, Katharina Staufer, Pascal Baltzer, et al.. (2018). The Efficacy of MRI in the diagnostic workup of cystic fibrosis-associated liver disease: A clinical observational cohort study. European Radiology. 29(2). 1048–1058. 17 indexed citations

12.

Jha, Pooja, Emina Halilbasic, Evan G. Williams, et al.. (2018). Genetic Regulation of Plasma Lipid Species and Their Association with Metabolic Phenotypes. Cell Systems. 6(6). 709–721.e6. 38 indexed citations

13.

Traussnigg, Stefan, Christian Kienbacher, Martin Gajdošík, et al.. (2017). Ultra‐high‐field magnetic resonance spectroscopy in non‐alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non‐alcoholic steatohepatitis and advanced fibrosis. Liver International. 37(10). 1544–1553. 36 indexed citations

14.

Trauner, Michael, Peter Fickert, Gideon M. Hirschfield, et al.. (2016). norUrsodeoxycholic acid (norUDCA) improves cholestasis in primary sclerosing cholangitis (PSC) independent of ursodeoxycholic acid (UDCA) pre-treatment and response. Hepatology. 63. 4 indexed citations

15.

Wanek, Thomas, Emina Halilbasic, Michele Visentin, et al.. (2016). Influence of 24-Nor-Ursodeoxycholic Acid on Hepatic Disposition of [18F]Ciprofloxacin, a Positron Emission Tomography Study in Mice. Journal of Pharmaceutical Sciences. 105(1). 106–112. 5 indexed citations

16.

Trauner, Michael, Peter Fickert, Gideon M. Hirschfield, et al.. (2016). Norursodeoxycholic Acid Improves Cholestasis in Primary Sclerosing Cholangitis: Results of a Phase II Dose Finding Study. Journal of Hepatology. 64(2). S208–S209. 10 indexed citations

17.

Halilbasic, Emina, et al.. (2012). 345 NORURSODEOXYCHOLIC ACID MODULATES LPS-INDUCED INFLAMMATORY RESPONSE BY INTERFERING WITH NFKB SIGNALING PATHWAY. Journal of Hepatology. 56. S140–S140. 3 indexed citations

18.

Halilbasic, Emina, Thierry Claudel, & Michael Trauner. (2012). Bile acid transporters and regulatory nuclear receptors in the liver and beyond. Journal of Hepatology. 58(1). 155–168. 307 indexed citations

19.

Halilbasic, Emina, Romina Fiorotto, Peter Fickert, et al.. (2009). Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2 −/− mice†‡§. Hepatology. 49(6). 1972–1981. 119 indexed citations

20.

Zollner, Gernot, Martin Wagner, Tarek Moustafa, et al.. (2005). Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-α/β in the adaptive response to bile acids. American Journal of Physiology-Gastrointestinal and Liver Physiology. 290(5). G923–G932. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact